| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41574-020-0340-1 |
| P698 | PubMed publication ID | 32111974 |
| P50 | author | Marian Ludgate | Q43227313 |
| P2860 | cites work | Teprotumumab for the Treatment of Active Thyroid Eye Disease | Q92873427 |
| Teprotumumab for Thyroid-Associated Ophthalmopathy. | Q34556184 | ||
| Cigarette smoking and thyroid eye disease: a systematic review | Q36596473 | ||
| The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy | Q36811289 | ||
| TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy Pathogenesis | Q36965291 | ||
| Autoantibodies to the IGF1 receptor in Graves' orbitopathy | Q46825815 | ||
| Below the Surface: IGF-1R Therapeutic Targeting and Its Endocytic Journey | Q90632604 | ||
| Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy | Q91445468 | ||
| New insights into the pathogenesis and nonsurgical management of Graves orbitopathy | Q92335694 | ||
| P921 | main subject | eye disease | Q3041498 |
| P577 | publication date | 2020-02-28 | |
| P1433 | published in | Nature Reviews Endocrinology | Q2079257 |
| P1476 | title | Shining a light on thyroid eye disease |
Search more.